arrow
Return

DNA sequencing using polymerase substrate-binding kinetics

delete2015-01-23
delete17
delete
OA
AI
M
Michael J. R. Previte
C
Chunhong Zhou
M
Matthew W. Kellinger
R
Rigo Pantoja
C
Cheng-Yao Chen
J
Jin Shi
王贝贝 (Beibei Wang)
A
Amirali Kia
S
Sergey S. Etchin
J
John Vieceli
A
Ali Nikoomanzar
E
E.K. Bomati
C
Christian Johannes Gloeckner
M
Mostafa Ronaghi
M
Molly M. He *
DOI:10.1038/ncomms6936delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Next-generation sequencing (NGS) has transformed genomic research by decreasing the cost of sequencing. However, whole-genome sequencing is still costly and complex for diagnostics purposes. In the clinical space, targeted sequencing has the advantage of allowing researchers to focus on specific genes of interest. Routine clinical use of targeted NGS mandates inexpensive instruments, fast turnaround time and an integrated and robust workflow. Here we demonstrate a version of the Sequencing by Synthesis (SBS) chemistry that potentially can become a preferred targeted sequencing method in the clinical space. This sequencing chemistry uses natural nucleotides and is based on real-time recording of the differential polymerase/DNA-binding kinetics in the presence of correct or mismatch nucleotides. This ensemble SBS chemistry has been implemented on an existing Illumina sequencing platform with integrated cluster amplification. We discuss the advantages of this sequencing chemistry for targeted sequencing as well as its limitations for other applications.
Keywords:
LABEL-FREE DETECTION
SINGLE-MOLECULE
PROTEIN
EVOLUTION
EXPANSION
REPEATS
MODE
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Nature Communications cover
Nature Communications
IF:
15.7
Papers:
9.2W
Citations:
91.2W

Organization

I
illumina
Scholars:
1.1K
Papers: 463
Citations: 1